Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsResearch in context

Summary: Background: Conventional dendritic cells (cDCs), are central to antitumour immunity, but their low prevalence in tumours limits the efficacy of immunotherapies. FLT3L is a key growth factor regulating cDCs development in the bone marrow. It expands cDCs when administered exogenously, favou...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EBioMedicine
Hlavní autoři: Jérémie Decalf, Evangeline Toy, Dongping He, Radhika Kenkre, Amy M. Berkley, Devon Wong, Mandy Kwong, Yee-Seir Kee, Yue Sun, Srividya Myneni, Xiangdan Wang, Ahmad Ebtikar, Anthony Ancheta, Yanli Yang, Hok Seon Kim, Nga Tang, Debarko Banerji, Elaine Mai, Pranay Dogra, Meredith McLerie, Alan G. Gutierrez, Geraldine Strasser, Gautham K. Rao, Matt Betzenhauser, Wilson Phung, Peter Day, Wendy Sandoval, Ayse Meric Ovacik, Pamela Chan, Shomyseh Sanjabi, Laetitia Comps-Agrar, Sivan Cohen, James A. Ernst, Greg A. Lazar, Christopher C. Kemball, Iraj Hosseini, Yichin Liu, Jill M. Schartner, Travis W. Bainbridge, Christine Moussion
Médium: Článek
Vydáno: Elsevier 2025-08-01
Témata:
Dendritic cells
Cancer immunotherapy
FLT3L
Innate immunity
Adaptive immunity
On-line přístup:http://www.sciencedirect.com/science/article/pii/S235239642500266X
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Internet

http://www.sciencedirect.com/science/article/pii/S235239642500266X

Podobné jednotky